Clinical Trial Update: Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypofractionated radiotherapy followed by hypo-boost for local advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED